NCT00108264View on ClinicalTrials.gov

Tumor RNA Transfected Dendritic Cell Vaccines

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Study Completion Date

September 30, 2005

Conditions

Prostate Cancer

Interventions

BIOLOGICAL

Tumor RNA transfected dendritic cells

Trial Locations (1)

27705

Durham VA Medical Center, Durham

All Listed Sponsors

lead

US Department of Veterans Affairs

FED

NCT00108264 - Tumor RNA Transfected Dendritic Cell Vaccines | Biotech Hunter | Biotech Hunter